该例患者患了重症肝炎，肝脏失代偿。
This patient developed severe hepatitis with hepatic decompensation.
探讨艾灸加中药治疗失代偿肝病腹泻的临床疗效。
To discuss the clinical effect of decompensated diarrhea of liver disease treated with argyi moxibustion added with traditional Chinese drug (TCD).
拉米夫定治疗乙型肝炎肝硬化失代偿期的临床观察。
Clinical Observation of Lamivudine for Decompensated Cirrhosis Resulting from Chronic Hepatitis b.
健康教育干预对肝硬化失代偿期患者生活质量的影响。
Effect of health educational intervention on life quality of patients with decompensated liver cirrhosis.
结果表明：暗紫与紫绛舌多为失代偿性呼吸性酸中毒；
The results were: in most cases, purple tongue or dark purple tongue meant decompensated respiratory acidosis;
目的探讨肝硬化失代偿期合并肝性胸水患者的临床特点。
Objective To investigate the clinical features of decompensate cirrhosis patients with pleural effusion.
我认为在无失代偿的患者，没有发生乳酸酸中毒的风险。
I don't think that there is any significant risk of lactic acidosis in patients without decompensated disease.
经治疗后1例角膜失代偿外院角膜移植，其余恢复良好。
All eyes restored well after treatment except 1 eye which was treated by coneal transplantation because of coneal decompensatory.
目的探讨肝硬化失代偿期老年患者的营养管理方法和效果。
Objective To explore the methods and effect of nutrition management in old patients with liver cirrhosis at decompensation stage.
目的观察生大黄联合常规疗法治疗失代偿性心力衰竭的临床疗效。
Objective To observe the clinical efficacy of raw rhubarb powder and routine therapy in the treatment of decompensated heart failure.
方法：随机选择正常肝脏、代偿期和失代偿期肝硬化各100例。
Methods: Normal cases compensated cirrhosis and decompensated cirrhosis each 100 cases respectively were selected at random.
结论肝硬化失代偿期患者可能存在下丘脑—垂体—性腺轴功能紊乱。
Conclusion There may be dysfunction of hypothalamics-pituitary-gonadal axis system in male patients with cirrhosis decompensation.
目的：确定长节段固定融合至L5或S1后矢状面失代偿危险因素。
Objective. To determine the risk factors of sagittal decompensation after long instrumentation and fusion to L5 or S1.
目的：探讨肝硬化失代偿期腹水与胆囊壁增厚的临床关系及其诊断价值。
Objective: to investigate the clinical relationship and diagnostic value of ascites and gallbladder wall thickening during hepatocirrhosis decompensation.
住院的患者，绝大部分都是有肝硬化、肝癌和肝功能失代偿比较重的病人。
Hospital patients, the majority is liver cirrhosis, liver cancer and liver decompensation heavier patients.
结果代偿性肝硬化组服用软肝片后效果明显，失代偿性肝硬化组无明显疗效。
Results the curative effect on the compensatory cirrhosis treated group was significantly better than the decompensated cirrhosis group.
方法对67例失代偿肝硬化并发肺部感染患者的临床资料进行了回顾性分析。
Methods a retrospective analysis was made in 67 cases with decompensated cirrhosis suffered from the pulmonary infection.
结论：腹内压升高普遍存在于急性失代偿性心力衰竭患者，与肾功能损害相关。
Conclusions: Elevated IAP is prevalent in patients with ADHF and is associated with impaired renal function.
目的：探讨安络化纤丸和还原型谷胱苷肽联合治疗失代偿期肝硬化的临床疗效。
Objective: To investigate the curative effects of An-luo Hua-xian pill and reduced glutathione on decompensated hepatic cirrhosis.
外源性的脑钠肽可以显著改善急性失代偿性心力衰竭的症状，已有相关药物问世。
Exogenous brain natriuretic peptide can significantly improve acute decompensated heart failure symptoms, related drugs already available.
结果肝硬化患者血、尿nag水平明显高于正常对照，失代偿期明显高于代偿期。
Results the results indicated that the NAG levels of patients with liver cirrhosis were higher than those of controls.
《国际肝病》：目前对于阻止失代偿肝硬化进展或逆转肝硬化有哪些药物治疗进展？
Hepatology Digest: What advances in pharmacological treatment can halt progression to decompensated cirrhosis or reverse cirrhosis?
尿血管紧张素原水平预测AKI在急性失代偿性心力衰竭：一项前瞻性研究两阶段。
Urinary Angiotensinogen Level Predicts AKI in Acute Decompensated Heart Failure: a Prospective, Two-Stage Study.
结论饮食干预对肝硬化失代偿期的治疗有重要意义，而且对患者的预后也有重要作用。
Conclusion: dietary interventions for the treatment of decompensated cirrhosis is important period, and the prognosis of the patients with also have an important role.
目的探讨脉冲组织多普勒(PW - TDI)评价肝硬化失代偿期右心功能的临床价值。
Objective To investigate the value of PW-TDI for estimating right ventricular function in the patients with hepatic cirrhosis.
目的：探讨肝硬化失代偿期并发自发性细菌性腹膜炎(SBP)危险因素，提高早期诊断率。
AIM: to investigate the risk factors of decompensated cirrhosis complicated with spontaneous bacterial peritonitis (SBP), and to improve the rate for early diagnosis rate.
目的：探讨在西药综合治疗基础上加用中药“化瘀益气汤”治疗失代偿期肝硬化患者的临床疗效。
Objective:To explore the therapeutic efficacy of Huayu Yiqi Decoction on the basis of western medicine in treatment of decompensatory liver cirrhosis.
目的：探讨在西药综合治疗基础上加用中药“化瘀益气汤”治疗失代偿期肝硬化患者的临床疗效。
Objective:To explore the therapeutic efficacy of Huayu Yiqi Decoction on the basis of western medicine in treatment of decompensatory liver cirrhosis.
应用推荐